PatientsVille.com Logo

ANHEDONIA and Augmentin

PatientsVille

ANHEDONIA Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for ANHEDONIA

ANHEDONIA treatment research studies

Augmentin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Augmentin Side Effects

Diarrhoea (341)
Pruritus (324)
Rash (236)
Pyrexia (227)
Jaundice (205)
Erythema (198)
Alanine Aminotransferase Increased (194)
Dyspnoea (186)
Urticaria (180)
Anaphylactic Shock (179)
Vomiting (173)
Aspartate Aminotransferase Increased (168)
Blood Alkaline Phosphatase Increased (164)
Nausea (152)
Abdominal Pain (145)
Hypotension (136)
Cholestasis (136)
Hepatitis Cholestatic (134)
Gamma-glutamyltransferase Increased (130)
Malaise (119)
Hypersensitivity (113)
Blood Bilirubin Increased (108)
Rash Maculo-papular (104)
Face Oedema (103)
Asthenia (98)
Hepatitis (96)
Toxic Skin Eruption (92)
Abdominal Pain Upper (89)
Anaphylactic Reaction (86)
Renal Failure Acute (79)
Chromaturia (78)
Oedema Peripheral (74)
Eosinophilia (74)
Purpura (73)
Angioedema (73)
Dizziness (71)
Anaemia (69)
Bronchospasm (69)
International Normalised Ratio Increased (69)
Thrombocytopenia (67)
Tachycardia (66)
Rash Erythematous (65)
Inflammation (63)
Oedema (63)
Fatigue (61)
Pain (54)
Dehydration (54)
Anorexia (53)
Death (53)
Blood Pressure Decreased (53)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

3rd day on augmentin and i'm getting chest pain didn't think it could be related and really bad nausea when I took it this morning. They don't list that as a side effect.

And it has blister now ,,,im afraid i dont know what to do,,,

Augmentin 625 ; ive been on it for 2 days,feeling sick and central chest pain [ like bad heartburn]

Augmentin 625: 2x a day I've been on it for 2 days. Experienced unexplained joint pains and swelling of my hands, feet & face. Can see flashes on my left eye on the 2nd day. Have also noticed that I always want to eat.

Buna imi poate spune si mie cineva ce contine augumentinu ca eu sunt alergica la amoxicilina

Can augmentine 625 mg twice daily for five days cause as a side effect Hyperthermia

Doctor had me take amoxicillin 500mg because of sinus infection. I toke 4x500mg for 10days. It cleared up the infection but I have had acute gout attacks for over a month. my feet/hands/wrists/knees have developed terrible pain to the point that I co

Due to elevated liver enzyme levels and an elevated ANA, my previous doctor gave me a diagnosis of autoimmune hepatitis. After reviewing my charts, my current doctor believes that it was an autoimmune response to 3 back-to-back courses of amoxicillin

Has anyone developed boday aches anda fever following only a second dose? I was perfectly fine,no fever just abronchial inflamation. feel horrible!

I am on it for second day too. Only side effects I have had was diarrhea, slight headache, and for some reason I have a herpes blister on my hand, which is where the virus lies dormant (until now). I am hoping the blister will go away right after I g

ANHEDONIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Depression and Dopamine Transporter Function Study Using C-11 Altropane
Conditions: Major Depressive Disorder;   Anhedonia
Intervention:
Outcome Measures: 11C-Altropane Binding;   Behavioral Performance in Probabilistic Reward Task;   Brain Activity during Instrumental Learning Task;   Behavioral Performance in Instrumental Learning Task;   Behavioral Performance in the Social Reinforcement Learning Task;   Questionnaire Data;   Behavioral Performance in Implicit Learning Serial Reaction Time Task
2 Recruiting Effects of Quitting Study A Test of Pre-clinical Findings
Condition: Smoking
Intervention: Behavioral: Smokers cease smoking
Outcome Measures: Responses to Effort Expenditure for Rewards Task (EEfRT) Test;   Rewarding Events Scale score.;   Delayed Discounting;   Self-reports of Anhedonia and Apathy
3 Recruiting Effects of Bupropion in Depression
Condition: Depression
Intervention: Drug: Bupropion
Outcome Measures: Change in haemodynamic (i.e. BOLD signal) response;   Change in questionnaire measures of subject mood and Anhedonia;   Change in accuracy and reaction time
4 Recruiting Brain Mechanisms of Emotion and Motivation: A Mind-Body Study
Conditions: Acute Stress;   Anhedonia;   Healthy
Intervention:
Outcome Measures: Brain Activity during Instrumental Learning Task;   Change in Behavioral Performance in Instrumental Learning Task;   Behavioral performance in Effort-Expenditure for Rewards Task;   Change in Questionnaire Data;   Change in Behavioral Performance in Probabilistic Reward Task;   Life Events and Difficulties (LEDS) interview;   Change in salivary hormone levels;   Salivary genetic analysis;   Change in inflammatory cytokine levels in blood plasma;   Behavioral Performance in Instrumental Learning Task;   Change in Behavioral performance in Reaction Time task
5 Recruiting The Effect of CBT- Based Weight Loss Program on Eating Behavior, Weight Loss Result and Risk for Coronary Heart Diseases and Type 2 Diabetes
Conditions: Obesity;   Hypercholesterolemia;   Diabetes Mellitus, Type 2;   Anhedonia
Intervention: Behavioral: Cognitive behavioral therapy -based weight loss program
Outcome Measures: change in weight;   change in eating behavior;   change in total cholesterol,HDL, LDL,Trigly and glucose;   DNA;   change in incretins
6 Unknown  Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)
Conditions: Abnormal Mental State;   Schizophrenia
Intervention: Drug: Quetiapine(Seroquel-XR) 50~800mg a day
Outcome Measures: California Verbal Learning Test;   verbal & spatial 2-back test, Digit Span, 3-7 CPT, WCST, Rey-CFT, TMT A & B, COWAT, SOPS, PANSS, SAS, PAS, AIHQ, BIS
7 Recruiting Nicotine Withdrawal Symptoms and Smoking Relapse
Condition: Nicotine Dependence
Intervention:
Outcome Measures: Change in BOLD signal and FC related to task parameters, Behavioral performance, and Self-reported craving, withdrawal symptoms and mood/affect.;   MRS for glutamate concentration, Plasma ACTH and cortisol, Resting state CBF, ERP and EEG measures, craving and physiological responses to physical drug cues, self-report characterization measures, & amp; structural MRI and DTI data.
8 Unknown  Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy
Conditions: Chronic Pain;   Opioid Abuse, Unspecified Use
Interventions: Behavioral: Mindfulness-Oriented Recovery Enhancement;   Behavioral: Conventional Support Group (SG)
Outcome Measures: Pain severity, pain functional interference;   Opioid craving;   Opioid misuse behaviors;   Well-being;   Attentional bias;   Psychophysiological cue-reactivity;   Emotional response inhibition;   Pain coping strategies;   Anhedonia;   Fear of pain;   Mindfulness;   Positive reappraisal
9 Recruiting Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia
Condition: Schizophrenia; Negative Type
Intervention: Procedure: Deep Brain Stimulation
Outcome Measure: Schedule for the Assessment of Negative Symptoms (SANS)
10 Unknown  Deep Brain Stimulation for the Treatment of Refractory Anorexia Nervosa
Condition: Anorexia Nervosa
Intervention: Procedure: Deep Brain Stimulation
Outcome Measures: Eating Disorder Related Preoccupations and Rituals;   Depression;   Anxiety;   Quality of Life
11 Unknown  Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia
Conditions: Chronic Cannabis Users;   Healthy Subjects
Interventions: Procedure: Magnetoencephalograph (MEG);   Behavioral: Cambridge Neuropsychological Test Automated Battery (CANTAB).;   Behavioral: Experimental: Scale for the Assessment of Negative Symptoms (SANS) and the Positive and Negative Syndrome Scale (PANSS)
Outcome Measures: Clinical Measure;   Cognitive Measure;   Electrophysiological Measure
12 Recruiting Recognition and Early Intervention on Prodrome in Bipolar Disorders
Condition: Bipolar Disorder
Interventions: Other: aerobic exercise;   Other: psychoeducation
Outcome Measures: Change from Baseline in Clinical Global Impressions (CGI) Scale at 12 weeks;   Diagnostic status;   Change from Baseline in Hamilton Depression Rating Scale at 12 weeks;   Change from baseline in Young Mania Rating Scale at 12 weeks;   Change from baseline in Brief Psychiatric Rating Scale at 12 weeks;   Change from baseline in Hamilton Anxiety Rating Scale at 12 weeks;   Change from baseline in Global Assessment Scale at 12 weeks
13 Recruiting Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion
Condition: Major Depressive Disorder
Interventions: Behavioral: psychometric tests;   Device: MRI;   Device: transcranial doppler and TPI;   Behavioral: explicitative interview
Outcome Measures: amplitude variations of heart and respiratory rate, cerebral pulsatility, galvanic skin response and startle as measure of physiological reactivity;   MRI data as measure of cerebral perfusion, volume of leukoaraiosis and default network (fMRI at rest);   ultrasound data of doppler as measure of cerebral pulstility;   score of psychometric tests as measure of emotional state;   spontaneous verbal production to emotional pictures and explicitative interviews